How to Get Finasteride in New Hampshire

At a glance
- Indication / male pattern hair loss (AGA) at 1 mg/day or benign prostatic hyperplasia (BPH) at 5 mg/day
- Prescription required / yes, Schedule-uncontrolled but requires clinician Rx in all 50 states
- Telehealth available in NH / yes, NH law permits synchronous and asynchronous telemedicine Rx
- 503A compounding / yes, NH-licensed 503A pharmacies may compound finasteride
- NH Medicaid coverage / not covered for AGA; BPH coverage subject to plan formulary
- Typical time to first dose / 24-72 hours via telehealth plus mail-order pharmacy
- Generic availability / yes, widely available; brand name is Propecia (1 mg) or Proscar (5 mg)
- PSA monitoring / baseline PSA recommended before starting; finasteride lowers PSA by approximately 50%
What Finasteride Is and Why You Need a Prescription
Finasteride is a type-II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). It requires a prescription in New Hampshire and every other U.S. state. The FDA originally approved the 5 mg tablet (Proscar) for BPH in 1992, then the 1 mg tablet (Propecia) for male androgenetic alopecia in 1997 [1].
The drug's mechanism is well-documented. DHT drives miniaturization of scalp follicles in genetically susceptible men, and blocking DHT production halts that process in most patients. In the key two-year Kaufman et al. trial (N=1,553), finasteride 1 mg/day increased hair count by a mean of 107 hairs per 1-inch target area versus a loss of 50 hairs in the placebo group at 24 months [2]. Hair regrowth takes time. Most men notice reduced shedding by month three and visible density changes by month six to twelve.
For BPH, the 5 mg dose reduces prostate volume by roughly 20-30% over 6-12 months [3]. The PLESS trial (N=3,040) found that finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% over four years [4].
Because finasteride affects hormone-sensitive tissues, New Hampshire clinicians require a brief evaluation before issuing any prescription. That evaluation can happen in person or via telehealth.
How NH Telehealth Law Applies to Finasteride Prescriptions
New Hampshire permits telemedicine prescribing under RSA 329:1-d, provided the prescribing clinician holds an active NH license or a valid multi-state compact license that includes New Hampshire. The NH Board of Medicine and the NH Board of Nursing both allow asynchronous (store-and-forward) intake for low-complexity, low-risk medications. Finasteride generally qualifies because no controlled substance is involved and the risk profile is well-characterized.
A 2023 American Urological Association white paper noted that "telehealth-based prescribing for androgenetic alopecia and BPH is appropriate when the clinician completes a thorough medical history, medication review, and documents informed consent regarding sexual side effects" [5]. NH-based telehealth platforms must comply with that standard.
Practical steps for telehealth access in NH are straightforward. You complete an online intake form covering your medical history, current medications, and symptoms. A licensed NH physician, nurse practitioner, or physician assistant reviews the intake, sometimes requesting photos of scalp hair distribution for AGA cases. If appropriate, the clinician sends an electronic prescription to your preferred NH pharmacy or a mail-order pharmacy licensed to ship into New Hampshire. The entire clinical review commonly completes within two to 24 hours on business days.
One important caveat: if your intake form reveals significant cardiovascular disease, a PSA over 4.0 ng/mL, prior prostate cancer, or sexual dysfunction that predates finasteride use, the telehealth provider may require an in-person visit before prescribing [6].
Step-by-Step: Getting a Finasteride Prescription in New Hampshire
Step 1. Choose your access route. Telehealth is fastest. In-person options include your primary care physician, a dermatologist for AGA, or a urologist for BPH.
Step 2. Prepare your health history. Collect your current medication list, any prior PSA values, and a brief description of your hair loss pattern or urinary symptoms. Clinicians will ask specifically about prior 5-alpha-reductase inhibitor use, liver disease, and sexual function [7].
Step 3. Complete the clinical evaluation. For telehealth, this is an online form plus optional video or photo review. For in-person visits, expect a 15-to-20-minute consultation.
Step 4. Discuss informed consent. NH clinicians must document that you were counseled on finasteride's boxed warning regarding exposure during pregnancy, the possibility of sexual side effects (reported in roughly 3.8% of men in registration trials), and the PSA-lowering effect that requires doubling any on-treatment PSA value for prostate cancer screening purposes [1][8].
Step 5. Receive the Rx. Electronic prescriptions route directly to a retail or mail-order pharmacy. Many telehealth platforms batch prescriptions with a 90-day supply to reduce refill burden.
Step 6. Monitor and follow up. A follow-up at three to six months confirms tolerability and early response. PSA should be rechecked at 6-12 months if baseline was obtained.
Labs and Baseline Testing Required in New Hampshire
No single statewide mandate dictates a required lab panel before finasteride. The decision is clinical. The Endocrine Society and the American Academy of Dermatology both recommend that clinicians consider a baseline PSA in men over age 40 before starting finasteride, because the drug suppresses PSA by approximately 50% and an untreated rising PSA could otherwise be masked [9][10].
Standard pre-treatment considerations for NH clinicians generally include the following. A baseline PSA matters for men 40 and older or those with a family history of prostate cancer. Liver function tests are occasionally ordered because finasteride is hepatically metabolized, though routine LFTs are not universally required. A testosterone level may be drawn if the clinician suspects a secondary cause for hair loss or if the patient has symptoms of hypogonadism.
For BPH patients, the AUA 2022 Guideline on Benign Prostatic Hyperplasia states: "Serum PSA should be measured in patients who are candidates for 5-alpha-reductase inhibitor therapy in whom the PSA result would affect management" [11]. That guidance applies in New Hampshire exactly as it does nationally.
Most telehealth platforms serving NH either order labs through a national network (LabCorp, Quest) with a draw site near you, or they accept recent lab results you upload. Turnaround on a basic PSA draw is typically 24-48 hours.
Who Can Prescribe Finasteride in New Hampshire
New Hampshire has a relatively open scope-of-practice environment. The following clinician types may legally prescribe finasteride in NH:
Physicians (MD and DO) hold full prescriptive authority under RSA 329. Nurse practitioners in NH have full independent prescriptive authority under RSA 326-B:11, meaning they do not require physician oversight to issue a finasteride prescription [12]. Physician assistants prescribe under RSA 328-D with a required collaboration agreement with a supervising physician, though that agreement does not require the physician to countersign individual prescriptions.
The practical takeaway: you do not need to see an MD specifically. An NP-only telehealth platform operating in New Hampshire can legally evaluate and prescribe finasteride without physician co-signature, provided the NP holds an active NH license. This expands access considerably for residents in rural areas such as Coos County, Carroll County, or Grafton County, where dermatology and urology access is limited.
Pharmacists in NH do not have independent prescribing authority for finasteride under current state law, though collaborative practice agreements in other states sometimes allow pharmacist-initiated finasteride. That model has not been adopted in NH as of mid-2025.
NH Pharmacies and 503A Compounding Options
Any retail pharmacy licensed by the NH Board of Pharmacy can dispense finasteride. Major chains with locations throughout the state (Manchester, Concord, Nashua, Portsmouth, Keene, and beyond) stock generic finasteride at competitive cash prices. GoodRx and similar discount programs can bring a 30-day supply of generic finasteride 1 mg to under $15 at many NH locations.
For patients who prefer a compounded formulation (for example, a topical finasteride solution, or a finasteride plus minoxidil combination), NH-licensed 503A compounding pharmacies may prepare these under USP Chapter 795 standards. The FDA defines 503A pharmacies as those that compound based on a valid prescription for an individual patient, not in anticipation of prescriptions [13]. Compounded oral finasteride is typically less common than compounded topical finasteride, because the commercial generic tablet is inexpensive and widely available.
Topical finasteride at concentrations of 0.1-0.25% has received growing research attention. A 2021 trial published in JAMA Dermatology (N=458) found that topical finasteride 0.25% solution applied once daily produced comparable hair count improvements to oral 1 mg with lower serum DHT suppression, suggesting a potentially reduced systemic side-effect profile [14]. NH 503A pharmacies can compound this formulation with a valid prescription.
Mail-order pharmacies licensed to ship into New Hampshire are also a practical option for anyone using a telehealth platform. Verify the pharmacy holds an active NH non-resident pharmacy license through the NH Board of Pharmacy before authorizing a shipment.
Transferring an Existing Finasteride Prescription to New Hampshire
Patients moving to NH from another state can transfer a finasteride prescription to any NH retail pharmacy, provided refills remain on the original prescription. Most pharmacy software systems handle interstate transfers electronically within minutes.
If you are switching from an out-of-state telehealth provider to a new provider, you will need a new prescription from an NH-licensed clinician. The prior provider's Rx does not automatically transfer prescriptive authority across state lines. Bring documentation of your previous dose, duration of use, and any baseline labs when you establish with a new clinician. This saves time and avoids repeating workup you have already completed.
For patients who were receiving finasteride from an out-of-state 503A compounding pharmacy, confirm that the compounding pharmacy either holds an NH non-resident pharmacy license or that your new provider can route your prescription to an NH-licensed alternative.
Pricing, Insurance, and NH Medicaid
New Hampshire Medicaid does not cover finasteride for androgenetic alopecia because the state classifies AGA treatment as cosmetic. Coverage for BPH indications depends on the specific Medicaid managed-care plan and formulary; as of 2025, most NH Medicaid MCOs include generic finasteride 5 mg on their formularies for BPH with prior authorization.
Commercial insurance coverage varies. Many plans cover finasteride 5 mg for BPH but exclude the 1 mg dose for hair loss. Prior authorization for the BPH indication typically requires documentation of an International Prostate Symptom Score (IPSS) of 8 or higher, a PSA value, and a prostate volume estimate from ultrasound or digital rectal exam if available [11].
Cash pricing for generic finasteride without insurance runs approximately $10-30 per month for 1 mg and $15-40 per month for 5 mg at NH pharmacies, depending on chain and discount card used. Patients who use the 5 mg tablet and split it into quarters (yielding approximately 1.25 mg per dose) often pay significantly less, though this approach should be discussed with your prescribing clinician because tablet-splitting alters the pharmacokinetic release profile slightly.
What to Expect: Timeline from Inquiry to First Dose
The timeline varies by access route. Understanding each pathway helps you plan.
Telehealth plus mail-order pharmacy: intake and clinical review takes 1-24 hours on a business day. Electronic Rx transmission is immediate. Standard mail delivery to an NH address takes 2-5 business days. Expedited shipping can deliver within 1-2 business days. Total time from starting the intake form to holding the medication: commonly 48-72 hours.
Telehealth plus local NH pharmacy: same intake timeline, but you pick up the prescription at a local pharmacy the same day the Rx is transmitted. Total time: as little as 24 hours.
In-person primary care or dermatology: appointment scheduling in NH currently runs 2-8 weeks for non-urgent visits in many areas, though urgent-care-style walk-in dermatology clinics exist in Manchester and Nashua. Once you see the clinician, the Rx is typically sent electronically that day.
Specialty urology for BPH: new patient urology appointments in NH run 3-12 weeks in most markets. Telehealth or primary care is a faster first-step option for uncomplicated BPH symptoms.
Safety Profile, Side Effects, and Monitoring
Finasteride's risk profile is established over three decades of post-marketing data. Sexual side effects (decreased libido, erectile dysfunction, ejaculatory dysfunction) occurred in 3.8% of men taking 1 mg in registration trials versus 2.1% on placebo. These effects resolved after discontinuation in the majority of participants [2][8].
A contested but important consideration is post-finasteride syndrome (PFS), a pattern of persistent sexual, neurological, and psychological symptoms reported by a subset of men after stopping the drug. The FDA added a label update in 2012 noting that sexual adverse events may persist after discontinuation [1]. The absolute prevalence of persistent symptoms remains debated in the literature, with estimates ranging from under 1% to several percent depending on the case definition used [15].
Finasteride also carries a class-labeled risk for male fetal harm through exposure to crushed or broken tablets during pregnancy. Women who are pregnant or may become pregnant should not handle crushed finasteride tablets [1].
PSA monitoring is the other key ongoing consideration. Because finasteride suppresses PSA by roughly 50%, any PSA measured during treatment should be doubled to estimate the true underlying value. A PSA that rises while on finasteride, even if the absolute value remains low, warrants prompt urological evaluation. The FDA label and the AUA guideline both specify this adjustment [1][11].
Liver toxicity is rare but documented; post-marketing reports of elevated liver enzymes exist, and clinicians should advise patients to report jaundice or right-upper-quadrant pain [6].
Getting Started: The Practical Path for Most NH Residents
For most NH men seeking finasteride for hair loss, the fastest compliant path is a telehealth platform with an NH-licensed prescriber, an electronic prescription sent to a local NH pharmacy or mail-order pharmacy, and a follow-up visit scheduled at the three-to-six-month mark. For BPH, consider whether primary care or urology is already part of your care team before adding a telehealth layer.
Bring a list of all current medications to your intake. Finasteride has a clinically meaningful interaction with other 5-alpha-reductase inhibitors (do not combine with dutasteride without explicit guidance), and some data suggest additive blood-pressure effects when combined with alpha-blockers commonly used in BPH management [3][7].
Men in NH with a family history of prostate cancer should discuss finasteride's nuanced relationship with prostate cancer screening before starting. The Prostate Cancer Prevention Trial (PCPT, N=18,882) showed that finasteride 5 mg reduced prostate cancer incidence by 24.8% overall but was associated with a higher rate of high-grade (Gleason 7-10) tumors in the treatment arm, a finding whose clinical significance remains under study [16].
The NH Board of Medicine contact number for verifying a clinician's license is (603) 271-1203, and the online license verification portal is available through the state's official licensing database. Confirm your telehealth provider's NH license there before sharing any health information or payment.
Frequently asked questions
›How do I get a finasteride prescription in New Hampshire?
›What labs are needed before finasteride in New Hampshire?
›Are there telehealth providers in New Hampshire prescribing finasteride?
›How long until I receive finasteride in New Hampshire?
›Can I transfer a finasteride prescription to New Hampshire?
›Are 503A pharmacies in New Hampshire licensed to ship finasteride?
›Who can prescribe finasteride in New Hampshire: MD vs NP vs PA?
›What documentation does prior authorization require in New Hampshire?
›Does NH Medicaid cover finasteride for hair loss?
›What is the standard finasteride dose for hair loss versus BPH?
›How long does finasteride take to work for hair loss?
›What are the main side effects of finasteride I should know before starting?
References
- U.S. Food and Drug Administration. Propecia (finasteride 1 mg) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- Roehrborn CG, Boyle P, Nickel JC, et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with BPH. Urology. 2002;60(3):434-441. https://pubmed.ncbi.nlm.nih.gov/12350480/
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with BPH (PLESS trial). N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
- American Urological Association. Telehealth and urologic care: policy statement. 2023. https://www.auanet.org/
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Finasteride. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548763/
- Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in BPH. N Engl J Med. 1996;335(8):533-539. https://pubmed.ncbi.nlm.nih.gov/8684407/
- Finasteride (Propecia) package insert: sexual adverse events. FDA Safety Communication, 2012. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Endocrine Society Clinical Practice Guideline: Androgenetic alopecia in men. https://academic.oup.com/jcem
- American Academy of Dermatology. Guidelines of care for androgenetic alopecia. J Am Acad Dermatol. 2017. https://pubmed.ncbi.nlm.nih.gov/26938712/
- American Urological Association. AUA Guideline: Benign Prostatic Hyperplasia (BPH). 2022 Update. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- New Hampshire Board of Nursing. Advanced practice registered nurse prescriptive authority: RSA 326-B:11. https://www.nh.gov/nursing
- U.S. Food and Drug Administration. Compounding: 503A vs 503B overview. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding
- Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. JAMA Dermatol. 2021. https://pubmed.ncbi.nlm.nih.gov/34524405/
- Traish AM, Mulgaonkar A, Giordano N. The dark side of 5alpha-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression. Korean J Urol. 2014;55(6):367-379. https://pubmed.ncbi.nlm.nih.gov/24955220/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer (PCPT). N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/